Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol to prevent muscle mass loss in immobilized subjects
2011-003541-17Phase 3Completed
- Sponsor
- Health Research Institute Hospital La Fe
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of allopurinol in muscle atrophy, sponsored by Health Research Institute Hospital La Fe. Primary endpoint: Role of xanthine oxidase in free radical production during immobilization. Started Oct 2011; status: completed.
02
Drugs
allopurinol
03
Conditions
muscle atrophy
Beyond the preview
Go deeper on 2011-003541-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003541-17.